These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 32732370)

  • 41. Quality of life measures in dysplastic Barrett's oesophagus are comparable to patients with non-dysplastic Barrett's oesophagus and do not improve after endoscopic therapy.
    Ratcliffe E; Britton J; Heal C; Keld R; Murgatroyd M; Willert R; McLaughlin J; Hamdy S; Ang Y
    BMJ Open Gastroenterol; 2023 Apr; 10(1):. PubMed ID: 37041020
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systematic review: geographical and ethnic differences in gastro-oesophageal reflux disease.
    Kang JY
    Aliment Pharmacol Ther; 2004 Oct; 20(7):705-17. PubMed ID: 15379831
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Barrett's oesophagus: endoscopic diagnosis and follow-up].
    Ponsot P
    Ann Chir; 2006 Jan; 131(1):3-6. PubMed ID: 16376849
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk of extra-oesophageal malignancies and colorectal cancer in Barrett's oesophagus and gastro-oesophageal reflux.
    Solaymani-Dodaran M; Logan RF; West J; Card T; Coupland C
    Scand J Gastroenterol; 2004 Jul; 39(7):680-5. PubMed ID: 15370691
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma.
    Wennerström EC; Risques RA; Prunkard D; Giffen C; Corley DA; Murray LJ; Whiteman DC; Wu AH; Bernstein L; Ye W; Chow WH; Vaughan TL; Liao LM
    Cancer Med; 2016 Sep; 5(9):2657-65. PubMed ID: 27384379
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systematic review with meta-analysis: the effects of family history on the risk of Barrett's oesophagus and oesophageal adenocarcinoma.
    Peters Y; van Grinsven E; Siersema PD
    Aliment Pharmacol Ther; 2021 Oct; 54(7):868-879. PubMed ID: 34383966
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease.
    Shearer C; Going J; Neilson L; Mackay C; Stuart RC
    Histopathology; 2005 Sep; 47(3):268-75. PubMed ID: 16115227
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The changing spectrum of gastroesophageal reflux disease.
    Todd JA; Johnston DA; Dillon JF
    Eur J Cancer Prev; 2002 Jun; 11(3):215-9. PubMed ID: 12131654
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antireflux surgery for Barrett's oesophagus.
    Lord RV
    ANZ J Surg; 2003 Apr; 73(4):234-6. PubMed ID: 12662234
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reflux, Barrett's oesophagus and adenocarcinoma: burning questions.
    Wild CP; Hardie LJ
    Nat Rev Cancer; 2003 Sep; 3(9):676-84. PubMed ID: 12951586
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis.
    Desai TK; Krishnan K; Samala N; Singh J; Cluley J; Perla S; Howden CW
    Gut; 2012 Jul; 61(7):970-6. PubMed ID: 21997553
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complications of gastro-oesophageal reflux disease.
    Parasa S; Sharma P
    Best Pract Res Clin Gastroenterol; 2013 Jun; 27(3):433-42. PubMed ID: 23998980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Leptin and the risk of Barrett's oesophagus.
    Kendall BJ; Macdonald GA; Hayward NK; Prins JB; Brown I; Walker N; Pandeya N; Green AC; Webb PM; Whiteman DC;
    Gut; 2008 Apr; 57(4):448-54. PubMed ID: 18178609
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A single centre's 20 years' experience of columnar-lined (Barrett's) oesophagus diagnosis.
    Caygill CP; Reed PI; Johnston BJ; Hill MJ; Ali MH; Levi S
    Eur J Gastroenterol Hepatol; 1999 Dec; 11(12):1355-8. PubMed ID: 10654794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
    Frazzoni M; Manno M; De Micheli E; Savarino V
    Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Review article: Barrett's oesophagus and associated adenocarcinoma--a UK perspective.
    Fitzgerald RC
    Aliment Pharmacol Ther; 2004 Dec; 20 Suppl 8():45-9. PubMed ID: 15575873
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma.
    Pohl H; Pech O; Arash H; Stolte M; Manner H; May A; Kraywinkel K; Sonnenberg A; Ell C
    Gut; 2016 Feb; 65(2):196-201. PubMed ID: 26113177
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gastro-oesophageal reflux: the disease of the millennium.
    Navaratnam RM; Winslet MC
    Hosp Med; 1998 Aug; 59(8):646-9. PubMed ID: 9829061
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Estimating neoplasia detection rate (NDR) in patients with Barrett's oesophagus based on index endoscopy: a systematic review and meta-analysis.
    Parasa S; Desai M; Vittal A; Chandrasekar VT; Pervez A; Kennedy KF; Gupta N; Shaheen NJ; Sharma P
    Gut; 2019 Dec; 68(12):2122-2128. PubMed ID: 30872393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.